Business Wire

Backlight to Showcase Product Line Innovations Across Creative and Streaming Workflows at IBC 2023

7.9.2023 18:50:00 EEST | Business Wire | Press release

Share

Global media and entertainment technology company Backlight announced that it is returning to the International Broadcasting Convention (IBC) this month with many new product updates and integrations to share with the industry. Backlight will be at booth 1.D09 to showcase innovative solutions that improve the video content lifecycle for broadcasters, content creators, publishers and distributors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230907741048/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Global media and entertainment technology company Backlight will showcase its feature-rich solutions that reduce pain points across the video lifecycle for more streamlined production and monetization at the 2023 International Broadcasting Convention (IBC). (Graphic: Business Wire)

Request a meeting with Backlight at IBC here.

Backlight Product Updates and Integrations

Backlight’s feature-rich solutions allow broadcasters and rights owners to create more content, distribute everywhere, unlock new revenue streams, and manage media and creative projects in the cloud intelligently and economically. The latest updates to its products to reduce pain points across the video lifecycle for more streamlined production and monetization include:

  • Wildmoka Live Studio: Backlight’s new digital-first live production platform. Backlight will demonstrate how Live Studio’s single interface makes it easy to tailor an existing live stream, or create a new one, from multiple live sources, clips, graphics and images, while preserving brand consistency with pre-configured production rooms and templated destinations. With the browser-based Live Studio, customers quickly generate platform-specific, low-latency content experiences and engage broader audiences through simultaneous distribution to any digital destination.
  • AI-assisted inventory creation within Zype Playout. Backlight’s ability to detect ad opportunities using machine learning is combined with low latency ad routing, device targeting, and a custom approach to ad macros in the newest version of Zype Playout. Customers have seen 516% increases in ad inventory, 15% increases in fill rate and 44% improvements in ad rendering when compared to leading playout providers.
  • Asset management, cloud production and content distribution – simplified. Backlight will showcase how easy it is to pull assets from any storage managed by iconik into Wildmoka’s live production environment for hyperdistribution as well as workflows for metadata-intelligent live-to-archive.
    • Add media management, review and collaboration to live media management workflows and scale up in the cloud for key events.
    • Push clips or archived content from Wildmoka to iconik for long-term storage, quick discovery, and reutilization in marketing initiatives – all in a browser.
  • New features and integrations for iconik, ftrack and cineSync increase creative workflow speed, flexibility and control.
    • iconik’s Favoriting functionality allows quicker retrieval of key assets, and updates to Collections now provide detailed insights into their sizes and creation history to empower better storage decision-making and resource allocation.
    • iconik demos will include a forthcoming integration with Apple's Final Cut Pro X that empowers users to effortlessly import/export iconik media directly into their FCPX editing environment and an updated integration with the powerful media review and approval solution cineSync.
    • cineSync expands format and standards support with OTIOZ playback, USD support and new ways to manage colors and notes in cineSync 5
    • ftrack Studio offers next-level precision for creative reviews by adding Wacom and stylus support and increased control for production tracking with new task scheduling and notification options.

Backlight’s Leaders to Share Insights on Monetizing Content and Remote Production

Leaders from Backlight will participate in two thought leadership forums at IBC—the SVG Sport Production Summit and the DPP Espresso Summit:

SVG Europe Sport Production Summit | Thursday, September 14, 2023 at 15:05 CET

  • Christophe Messa, Backlight’s director of Strategic Partners will join panelists from Tinkerlist, Spiideo, and Vislink for a discussion on Making and Monetizing Sports Content at the SVG Europe Sports Production Summit. Attendees will learn about best practices and new strategies that right owners are using to generate income for sports content, including on social media, OTT platforms and apps.

DPP Espresso Summit | Friday, September 15, 2023 at 0930 CET

  • At this breakfast briefing hosted by DPP, Backlight Chief Product Officer, Mike Szumlinski and other panelists will discuss hybrid working and the technology needed to support remote production more broadly.

Backlight is Shortlisted for Three Awards at IBC

  • The International Trade Association for the Broadcast & Media Industry (IABM) has shortlisted Backlight’s media management platform, iconik, for a BaM award in the Manage category. Iconik revolutionizes how organizations of all sizes manage, share and collaborate on digital assets.
  • Backlight’s Zype Apps Creator solution was shortlisted for an award by CSI Magazine in the Best VoD or content-on-demand solution category. Zype Apps Creator is Backlight’s turnkey solution for building streaming apps to deliver and monetize branded experiences across owned and operated and popular third-party platforms.
  • Backlight has been shortlisted for a Corporate Star award for Best Charity/CSR initiative for its collaboration with HUFO, a student-led film organization at Howard University that provides students with the resources they need to launch and leverage careers within the entertainment industry.

About Backlight

Backlight is a global media technology company that dramatically improves every stage of the video and entertainment content lifecycle, from creation through monetization. Backed by $200M in funding from PSG, Backlight has acquired six leading media software companies since launching in 2021. Video-forward organizations solve their mission-critical business and operational challenges by partnering with Backlight’s two divisions: Backlight Creative and Backlight Streaming. Backlight Creative provides award-winning software solutions for secure and efficient media management, production tracking and creative collaboration, including iconik, ftrack, Gem and Celtx. Backlight Streaming provides cloud-based OTT video streaming, content management, media production, hyperdistribution, and monetization software, including Zype and Wildmoka, to the world’s most innovative publishers and broadcasters. For more information visit backlight.co.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Bubble Agency for Backlight | backlight@bubbleagency.com
Backlight | media@backlight.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye